Helical (Spiral) Tomotherapy UW Helical Tomotherapy Unit James S Welsh, MS, MD

advertisement

Novel Clinical Applications of IMRT

James S Welsh, MS, MD

Department of Human Oncology

University of Wisconsin, Madison

Linac

CT Couch

Helical (Spiral) Tomotherapy

Ring

Gantry

CT

Detector

X-Ray Fan

Beam

Binary

Multileaf

Collimator

Binary MLC Leaves

Helical

Fan Beam

Helical

Scanning

Helical (Spiral) Tomotherapy

X-Ray Beam

Binary MLC Leaves

Helical Fan Beam Delivery

UW Helical Tomotherapy Unit

Status June 2003

• MVCT scans obtained on 10 lung and 10 prostate cancer patients

• 9 dogs treated

• 10 human patients treated

• 9 palliative

• 1 definitive

MVCT of an Anesthetized Dog with a

Sinus Tumor Advantages of Helical

Tomotherapy

• CT component allows real-time imaging of patients to verify set-up and detect variations in positioning

• Relative Simplicity

• An optimal means of delivering co-planar therapy

• Adaptive Radiotherapy

• Conformal Avoidance

• Wide range of IMRT applications

Sinus

Tumor

Eroded

Bone

Page 1

MVCT Before Our First Patient Treatment MVCT of a Lung Cancer Patient #1 at 3 cGy

Soft Tissue Window Lung Window

Target Volume

Lung

Tumor

MVCT of a Lung Cancer Patient # 2 at 3 cGy

Soft Tissue Window Lung Window

MVCT of a Prostate

Cancer Patient at 2.5 cGy

Prostate

Lung

Tumor

Advantages of Helical

Tomotherapy

• CT component allows real-time imaging of patient to verify set-up and detect variations in positioning

• Relative Simplicity

• An optimal means of delivering co-planar therapy

• Adaptive Radiotherapy

• Conformal Avoidance

95%

90%

50%

20%

Preliminary Tomotherapy

Planning

Page 2

95%

90%

50%

20%

Preliminary Tomotherapy

Planning

15

10

5

25

20

0

3D plans

Tomotherapy

P1 P2

Tomotherapy decreases mean NTD (spinal cord)

Spinal cord NTDmean

P3

Patient

P4 P5 Mean

Conformal Avoidance

• Wide field XRT is frequently employed to target regional micrometastatic extension

• This regional disease extension is not precisely defined in terms of anatomic detail

• As a consequence, normal critical tissues are frequently irradiated and yield toxicities

• Conformal avoidance can “shield” these structures and improve the therapeutic index by decreasing these often permanent and debilitating NTCPs

– Salivary glands: Xerostomia/Dental hygiene/Osteonecrosis

– Oto-acoustic apparatus: Hearing/Balance

– Optic/Lacrimal tissues: Vision/Xerophthalmia/Corneal complications

Rationale for Conformal

Avoidance Radiotherapy

• The gross tumor volume (GTV) may not be clearly visible

• Uncertainty in defining the clinical target volume (CTV)

• The planning target volume (PTV) may be uncertain

• The target dose is limited by normal sensitive tissue

• Conformal avoidance is the ideal paradigm to treat suspected regional/nodal involvement

Conformal dose-distribution with tomotherapy

Page 3

Continuum Between Conformal

Therapy and Conformal Avoidance

Know where tumor is and will not harm sensitive tissue

• Don’t really know where tumor is

• May miss part of target if overly conformal

• …..and still harm sensitive tissue

The Mantle

• Successfully used for many decades

• A classic example of the need to treat invisible microscopic regional disease

• Generally not easy to duplicate using conformal therapy

• A potential application of conformal avoidance IMRT

• Can reduce dose to Thyroid, Larynx, Heart,

Spinal cord thereby reducing complications

• Can reduce dose to breast in young women

(possibly) reducing risk of future breast cancer

Conformal Mantle Field

Subtotal/Total Lymphoid

Irradiation

• Inverted-Y

• Can be effectively duplicated using IMRT via linac or helical tomotherapy

• Significantly less dose to sensitive normal structures than older techniques is possible

Conformal Avoidance Radiotherapy for A Mantle Equivalent using

Helical Tomotherapy

Spine

Lungs

Regional field

Larynx

Mediastinal

L.axila node

R.axila node

The dose should be

Divided by 10

Page 4

Mesothelioma

ROI slice 27

Dose Rate Cumulative Dose

50 %

80 %

90 %

Slice 31

50 %

80 %

90 %

Slice 36

50 %

80 %

90 %

Partial Breast Irradiation

• Good clinical results have been obtained using HDR brachytherapy

• Recent applications of partial breast irradiation using external beam approaches

• Visualization of target and immobilization of breast will be essential for success of this approach

Limited Field

Prone Breast

Page 5

Limited Field

Prone Breast

Skin

Muscle

Lt Lung Rt Lung

PTV

GTV

IMRT for complicated tumor volumes

• IMRT can handle complicated tumor volumes using either a conformal therapy or conformal avoidance approach

• High conformality of isodose curves

– Lower doses to surrounding normal structures

– Higher dose to tumor volume

Skull Irradiation

Lt Eye

Rt Optic Nerve

PTV

Rt Eye

Chiasm

Lumbar Spine Treatment

Kidneys PTV

Page 6

MVCT, Simple Contour, Plan & Treat Palliative Case: 30 Minutes Total

Setup ~3min

MVCT ~7min

Contour ~10min

Optimize ~5min

Delivery ~5min

Simple

Contour

Page 7

Summary

• Conformal avoidance radiotherapy, the complement to conformal radiotherapy, focuses on avoiding dose to normal tissue

• IMRT, especially helical tomotherapy appears particularly well-suited for conformal avoidance

• Many innovative clinical procedures will evolve from conformal avoidance IMRT

Potential Clinical Applications of

Conformal Avoidance IMRT

• Improved irradiation of nodal chains using the conformal avoidance strategy

– Improved “Mantle” and “Inverted-Y”

– Para-aortic irradiation for GYN, GU and lymphoid malignancies

• Brain-sparing total scalp irradiation

– Scalp-sparing whole brain irradiation

• Pacemaker/defibrillator avoidance

• Bone marrow ablation while sparing visceral organs

• Craniospinal Irradiation

Potential Clinical Applications of

Conformal Avoidance IMRT

• Accelerated partial breast irradiation

• Complicated tumor volumes

– mesothelioma

• Extracranial stereotactic radiotherapy

• Widespread metastatic disease?

– Visible disease handled with radiotherapy

– Microscopic disease handled by chemotherapy

– “Intermediate” disease identified by PET and handled by IMRT

Page 8

Download